For in vivo studies we used db/db type 2 diabetes mice as a model of DKD and Col4a3-/- mice as an experimental Alport syndrome model to determine presence and activity of the cGAS-STING pathway in the kidneys. This evidence concerns the gene CGAS and diabetic kidney disease.